Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aazib Irshad"'
Autor:
Ibrahim Tawhari, Patrick Hallak, Sofia Bin, Fatmah Yamani, Maria Safar-Boueri, Aazib Irshad, Joseph Leventhal, Mohammed Javeed Ansari, Paolo Cravedi, Lorenzo Gallon
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundBelatacept (Bela) was developed to reduce nephrotoxicity and cardiovascular risk that are associated with the chronic use of Calcineurin inhibitors (CNIs) in kidney transplant recipients. The use of Bela with early steroid withdrawal (ESW)
Externí odkaz:
https://doaj.org/article/b395cd1a38fe475aa95ebcdd32f8779a
Autor:
Marwah Muhammad, Ahmad Jahangir, Ali Kassem, Saud Bin Abdul Sattar, Abdullah Jahangir, Syeda Sahra, Muhammad Rafay Khan Niazi, Ahmad Mustafa, Zeeshan Zia, Fasih Sami Siddiqui, Waleed Sadiq, Danil Mishiyev, Aleena Sammar, Loai Dahabra, Aazib Irshad, Dany Elsayegh, Michel Chalhoub
Publikováno v:
Advances in Respiratory Medicine; Volume 90; Issue 4; Pages: 281-299
Clinical rationale for study: Despite advancements in critical care, the mortality rate of sepsis remains high, with an overall poor prognosis. There is a complex pathophysiology of a lethal cascade of cytokines and inflammatory proteins underlying s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cbe49d5679a89a38d845886fca9138a
https://doi.org/10.3390/arm90040038
https://doi.org/10.3390/arm90040038
Introduction: Glomerulonephritis is classified into several different pathological patterns, which are generally divided into non-proliferative or proliferative types. Glomerulonephritis accounts for 25-45% of cases of end-stage renal disease (ESRD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633e6315173e3db2271dd68d82ad87df
